NEOGEN CORPORATION (NASDAQ:NEOG) Files An 8-K Results of Operations and Financial Condition

0

NEOGEN CORPORATION (NASDAQ:NEOG) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition

On July18, 2017 Neogen Corporation issued a press release announcing results of operations for the fiscal quarter and full year periods ended May31, 2017. A copy of the press release is attached as Exhibit 99.1 to this report. This Form 8-K and the attached exhibit shall not be deemed “filed” for purposes of Section18 of the Securities Exchange Act of 1934, as amended, and are not incorporated by reference into any filing of the Registrant, whether made before or after the date of this report, regardless of any general incorporation language in the filing.

Item 2.02 Financial Statements and Exhibits

(d) Exhibits

99.1 Press Release dated July18, 2017


NEOGEN CORP Exhibit
EX-99.1 2 d427297dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE   CONTACT:    Steven J. Quinlan,…
To view the full exhibit click here

About NEOGEN CORPORATION (NASDAQ:NEOG)

Neogen Corporation develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. The Food Safety segment produces and markets diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation. The Animal Safety segment is primarily engaged in the production and marketing of products dedicated to animal health, including a range of consumable products marketed to veterinarians and animal health product distributors. The Animal Safety segment also provides genetic identification services. Additionally, the Animal Safety segment produces and markets rodenticides, disinfectants and insecticides to assist in the control of rodents and disease in and around agricultural, food production and other facilities.